LFST LIFESTANCE HEALTH GROUP INC revenue, earnings and financials
For the quarter ended June 30, 2026, LIFESTANCE HEALTH GROUP INC reported revenue of $435M (up 26.1% from a year earlier), net income of $23.6M and diluted EPS of n/a; over the last four quarters revenue was $1.58B and net income $50.6M; for the fiscal year ended December 2025 revenue was $1.42B, up 13.9% on the year before.
LFST annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.42B, gross profit n/a, operating income $24.1M, net income $9.66M (margin 0.7%), EPS n/a
- Fiscal year ended Dec 2024: revenue $1.25B, gross profit n/a, operating income −$31.6M, net income −$57.4M (margin -4.6%), EPS n/a
- Fiscal year ended Dec 2023: revenue $1.06B, gross profit n/a, operating income −$189M, net income −$186M (margin -17.6%), EPS n/a
- Fiscal year ended Dec 2022: revenue $860M, gross profit n/a, operating income −$210M, net income −$216M (margin -25.1%), EPS n/a
- Fiscal year ended Dec 2021: revenue $668M, gross profit n/a, operating income −$286M, net income −$307M (margin -46.0%), EPS n/a
LFST quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $435M (up 26.1% year over year), net income $23.6M, EPS n/a
- Quarter ended Mar 31, 2026: revenue $403M (up 21.2% year over year), net income $14.2M, EPS n/a
- Quarter ended Dec 31, 2025 (from the annual report): revenue $382M (up 17.4% year over year), net income $11.7M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $364M (up 16.3% year over year), net income $1.08M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $345M (up 10.6% year over year), net income −$3.79M, EPS n/a
- Quarter ended Mar 31, 2025: revenue $333M (up 10.8% year over year), net income $709K, EPS n/a
- Quarter ended Dec 31, 2024 (from the annual report): revenue $325M (up 16.0% year over year), net income −$13.8M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $313M (up 19.0% year over year), net income $709K, EPS n/a
- Quarter ended Jun 30, 2024: revenue $312M (up 20.3% year over year), net income −$23.3M, EPS n/a
- Quarter ended Mar 31, 2024: revenue $300M (up 18.9% year over year), net income −$21.1M, EPS n/a
- Quarter ended Dec 31, 2023 (from the annual report): revenue $281M (up 22.3% year over year), net income −$45.0M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $263M (up 20.8% year over year), net income −$61.6M, EPS n/a
- Quarter ended Jun 30, 2023: revenue $260M (up 23.9% year over year), net income −$45.5M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $253M (up 24.4% year over year), net income −$34.2M, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue $229M (up 20.7% year over year), net income −$46.7M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $218M (up 25.2% year over year), net income −$37.9M, EPS n/a
- Quarter ended Jun 30, 2022: revenue $210M (up 30.5% year over year), net income −$68.7M, EPS n/a
- Quarter ended Mar 31, 2022: revenue $203M (up 41.9% year over year), net income −$62.3M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $190M, net income −$108M, EPS n/a
- Quarter ended Sep 30, 2021: revenue $174M, net income −$120M, EPS n/a
LFST cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $146M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $107M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$16.9M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow $52.8M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow $9.42M, share buybacks n/a
LFST balance sheet
- Jun 30, 2026: cash $226M, total assets $2.18B, total liabilities $704M, shareholders' equity $1.48B, long-term debt $259M
- Mar 31, 2026: cash $195M, total assets $2.15B, total liabilities $668M, shareholders' equity $1.48B, long-term debt $262M
- Dec 31, 2025: cash $249M, total assets $2.20B, total liabilities $683M, shareholders' equity $1.52B, long-term debt $266M
- Sep 30, 2025: cash $204M, total assets $2.15B, total liabilities $656M, shareholders' equity $1.49B, long-term debt $269M
- Jun 30, 2025: cash $189M, total assets $2.15B, total liabilities $673M, shareholders' equity $1.47B, long-term debt $273M
- Mar 31, 2025: cash $134M, total assets $2.10B, total liabilities $648M, shareholders' equity $1.46B, long-term debt $276M
- Dec 31, 2024: cash $155M, total assets $2.12B, total liabilities $672M, shareholders' equity $1.45B, long-term debt $280M
- Sep 30, 2024: cash $103M, total assets $2.11B, total liabilities $671M, shareholders' equity $1.44B, long-term debt $279M
What is LFST's revenue?
LIFESTANCE HEALTH GROUP INC reported $1.58B of revenue over its last four quarters, through June 30, 2026.
Is LFST profitable?
Yes. LIFESTANCE HEALTH GROUP INC earned $50.6M over the last four quarters.